Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression.
AuthorsKeating, P J
Cromme, F V
Duggan-Keen, Margaret F
Snijders, P J
Walboomers, Jan M
Hunter, Robin D
Dyer, P A
Stern, Peter L
AffiliationCancer Research Campaign Department of Immunology, Paterson Institute for Cancer Research, Manchester, UK.
MetadataShow full item record
AbstractThe development of cervical carcinoma is strongly associated with specific types of human papillomaviruses (HPVs). A role for cellular immunity in cervical disease is supported by the increased occurrence of HPV-associated lesions in immunosuppressed individuals. Upon viral infection or malignant transformation, ensuing alterations in gene expression result in the generation of novel sets of peptides which can form complexes with specific HLA class I heavy chains and beta 2-microglobulin. These are then expressed at the cell surface as potential targets for specific T cells. In this study of 100 carcinomas HLA-A and -B class I expression by the tumour cells was down-regulated at one or more alleles in at least 73% of cervical carcinomas. Interference with the transporter associated with antigen presentation (TAP), which translocates cytosolic peptides from endogenously synthesised proteins (e.g. viral) into the lumen of the endoplasmic reticulum was found in 38% of the HLA class I down-regulated tumours. Loss of expression for common HLA class I alleles ranged from 36% to 71%, and such changes might be expected to influence specific immunogenic peptide presentation and consequent immune recognition. These results underline the importance of single as well as multiple allelic loss in cervical neoplasia and have important implications for attempts to intervene immunologically in cervical cancer.
CitationFrequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression. 1995, 72 (2):405-11 Br. J. Cancer
JournalBritish Journal of Cancer
- Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours.
- Authors: Cromme FV, van Bommel PF, Walboomers JM, Gallee MP, Stern PL, Kenemans P, Helmerhorst TJ, Stukart MJ, Meijer CJ
- Issue date: 1994 Jun
- Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer.
- Authors: Koopman LA, Corver WE, van der Slik AR, Giphart MJ, Fleuren GJ
- Issue date: 2000 Mar 20
- Mutations in TAP genes are common in cervical carcinomas.
- Authors: Fowler NL, Frazer IH
- Issue date: 2004 Mar
- Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.
- Authors: Cromme FV, Airey J, Heemels MT, Ploegh HL, Keating PJ, Stern PL, Meijer CJ, Walboomers JM
- Issue date: 1994 Jan 1
- Multiple mechanisms underlie HLA dysregulation in cervical cancer.
- Authors: Brady CS, Bartholomew JS, Burt DJ, Duggan-Keen MF, Glenville S, Telford N, Little AM, Davidson JA, Jimenez P, Ruiz-Cabello F, Garrido F, Stern PL
- Issue date: 2000 May